HOLD PM at $190.48 with mandatory two-tier trim framework operationalizing 8/26 lesson while honoring 8/21 lesson against Underweight
HOLD with mandatory two-tier trim framework operationalizes both the 8/26 lesson (trim triggers required for this setup matching its exact characteristics: upper Bollinger, sub-average volume, -3.12% 30-day return) and the 8/21 lesson (default to Hold with attached trim triggers rather than initiating Underweight, as premature de-risking surrenders alpha in this name). The 26.16x TTM P/E and 2.52 PEG justify trimming into strength rather than adding. Hard stop $183.50. Do NOT add at $190.48.
| Position | Action |
|---|---|
| Relief rally into $194-197 zone | Trim 10-15% of position |
| Confirmed weekly close <$186.67 (50 SMA) with expanding volume | Trim additional 10% of position |
| Breakout entry above $194.21 on >5M shares | Size any breakout add at half normal notional |
Philip Morris is a mega-cap defensive franchise undergoing a smoke-free transformation that the market has not fully priced, with record revenue, expanding margins, and a ZYN ULTRA regulatory catalyst creating asymmetric upside from current levels.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $190.76 | neutral |
| 50 SMA | $186.67 | bullish |
| 200 SMA | $171.49 | bullish |
| RSI (14) | 51.86 | neutral |
| MACD Line | 1.20 | neutral |
| MACD Signal Line | 0.97 | neutral |
| MACD Histogram | +0.22 | neutral |
| Bollinger Upper Band | $194.21 | neutral |
| Bollinger Middle Band (20 SMA) | $189.06 | neutral |
| Bollinger Lower Band | $183.91 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Successful retest of $186.67 with MACD compression
Then: Re-enter with defined risk
EV: +10+ (to $200-$205+) · concedes: Altria deal is not a 2026 earnings catalyst — first shipments not until 2027; Dividend coverage is tight at ~95% of TTM FCF; USD strength from higher-for-longer rates is a real translation headwind
PM faces asymmetric downside risk: premium valuation near 52-week highs, tight dividend coverage (~106% of FCF), persistent USD headwinds on 70%+ international revenue, and muted market reactions to catalysts (ZYN FDA, record Q2 revenue) all suggest the smoke-free transformation thesis is largely priced in, with a 10% downside scenario to $171 more likely than 7% upside to $203.80 fair value.
EV: +7% (to $203.80 fair value); bear argues -10% (to $171 200 SMA) is more likely · concedes: ZYN ULTRA FDA Marketing Authorization for 11 products is a real regulatory milestone; Smoke-free transformation is a genuine business evolution, not just narrative; IQOS is genuinely dominant in Japan and parts of Europe; PM does have some exposure to international growth markets that MO lacks
→ vs conservative: 26x P/E and PEG of 2.52 are not stretched metrics for a quality compounder; they confuse quality re-rating with a bubble, ignoring the record revenue, expanding margins, and low-beta defensive characteristics
→ vs conservative: Adding at $190.48 offers insufficient margin of safety given 4.67 ATR and dead zone between $194.21 breakout level and $186.67-$183.91 support; trader's plan sequences the entry to capture 8-10% from high-conviction confirmation rather than 3-5% from premature entry
→ vs neutral: Technical setup is coiled, not mixed; MACD and RSI at 51.86 indicate consolidation within strong secular uptrend, not absence of edge; this pattern resolves with powerful breakout when catalyst hits
→ vs neutral: Wait-and-see stance ignores that catalyst (FDA ZYN ULTRA authorization) has already arrived in current quarter; stock up only 0.2% post-earnings despite regulatory clearance for biggest U.S. growth market
→ vs neutral: Jackson Hole macro fears and Fed cut pricing are binary risks that don't materially affect addictive-demand companies; PM priced through COVID, 2022 rate shock, and every dollar rally since 2008
| ATR (14) |
| $4.67 |
| neutral |
| VWMA (90-day) | $189.27 | bullish |
| Today's Volume | 3,972,838 | neutral |
Support: 183.91 · 186.67 · 189.06 · 171.49 | Resistance: 194.21 · 196.66 · 200.17
PM is consolidating within a strong long-term uptrend, trading ~11% above the 200 SMA ($171.49). The short-term trend is neutral as price sits just below the 10 EMA ($190.76), while medium-term strength is confirmed above the 50 SMA ($186.67). RSI at 51.86 and contracting MACD histogram (+0.22) indicate waning near-term momentum, warranting a tactical HOLD stance. Key support zones at $186.67–$189.06 should attract buyers, with a bullish breakout above $194.21 targeting $200.17.
Market Cap
$296.88B
PE (TTM)
26.16x
Forward PE
20.77x
PEG Ratio
2.52
Price/Book
-34.59x
EPS (TTM)
$7.28
Forward EPS
$9.17
Dividend Yield
3.03%
Beta
0.40
Revenue (TTM)
$42.55B
Gross Profit (TTM)
$28.71B
EBITDA (TTM)
$18.02B
Net Income (TTM)
$10.84B
Gross Margin
~67.5%
Operating Margin
40.00%
Net Margin
25.56%
ROA
14.59%
Total Assets (Q2 2026)
$68.27B
Total Liabilities (Q2 2026)
$74.93B
Cash & Equivalents (Q2 2026)
$5.999B
Long-Term Debt (Q2 2026)
$42.37B
Total Debt (Q2 2026)
$49.11B
Net Debt (Q2 2026)
$43.11B
Treasury Stock
$35.46B
Goodwill & Intangibles (Q2 2026)
$27.10B
Working Capital (Q2 2026)
-$0.54B
Current Ratio (Q2 2026)
0.98
Book Value
-$5.51B
Tangible Book Value
-$35.68B
Net Debt/EBITDA
~2.4x
Free Cash Flow (TTM)
$9.71B
Annualized Dividends
~$9.2B
Quarterly Dividends
~$2.30B
52-Week High
$207.76
52-Week Low
$142.11
50-DMA
$186.69
200-DMA
$173.25
Implied Current Price
~$190
Strengths
Concerns
HOLD rating reflects a high-quality defensive franchise with exceptional cash generation and a new Q2 2026 revenue record, but premium valuation (26x PE, 2.5x PEG) and thin dividend coverage (~85% of FCF) limit incremental upside at current levels near 52-week highs. New positions are best initiated on pullbacks to the 50-DMA ($186.69) or 200-DMA ($173.25) for improved risk/reward.
Macro: Fed policy is firmly in 'higher-for-longer' mode with Polymarket pricing 88% probability of zero cuts in 2026 ($7.58M volume), supporting bond-proxy/defensive income trades but keeping USD firm and creating FX translation headwinds for PM's non-USD revenue. Jackson Hole speech (Aug 28) is a binary catalyst with Treasury yields edging higher into the event. US recession odds sit at 8% (soft-landing base case), while consumer bifurcation is evident with Gap cutting Old Navy guidance and Walmart -10% in a month, but Coca-Cola 'won a key consumer battle' — the same dynamic PM is seeing where pricing + mix can offset volume softness in defensives. Inflation and employment data unavailable (FRED API not configured).